Clinician Concepts of Cure in Adult Relapsed and Refractory Philadelphia-Negative B Cell Precursor Acute Lymphoblastic Leukemia: A Delphi Study

ConclusionsAlthough such terminology remains contested, clinicians would begin considering “cure” as early as 2 years provided the patient is off therapy, with most considering the term applicable by the third year.FundingAmgen Inc.

Source: Advances in Therapy - March 6, 2019 Category: Drugs & Pharmacology Source Type: research